Syngen BiotechLtd Past Earnings Performance

Past criteria checks 2/6

Syngen BiotechLtd has been growing earnings at an average annual rate of 12.2%, while the Pharmaceuticals industry saw earnings growing at 14.7% annually. Revenues have been growing at an average rate of 11.1% per year. Syngen BiotechLtd's return on equity is 12.7%, and it has net margins of 14.1%.

Key information

12.2%

Earnings growth rate

9.5%

EPS growth rate

Pharmaceuticals Industry Growth18.5%
Revenue growth rate11.1%
Return on equity12.7%
Net Margin14.1%
Last Earnings Update31 Mar 2024

Recent past performance updates

Recent updates

Does Syngen BiotechLtd (GTSM:8279) Have A Healthy Balance Sheet?

Mar 25
Does Syngen BiotechLtd (GTSM:8279) Have A Healthy Balance Sheet?

Should Syngen Biotech Co., Ltd. (GTSM:8279) Be Part Of Your Dividend Portfolio?

Feb 25
Should Syngen Biotech Co., Ltd. (GTSM:8279) Be Part Of Your Dividend Portfolio?

Did You Miss Syngen Biotech's (GTSM:8279) Impressive 104% Share Price Gain?

Feb 04
Did You Miss Syngen Biotech's (GTSM:8279) Impressive 104% Share Price Gain?

Is Syngen Biotech Co., Ltd.'s (GTSM:8279) Latest Stock Performance Being Led By Its Strong Fundamentals?

Jan 14
Is Syngen Biotech Co., Ltd.'s (GTSM:8279) Latest Stock Performance Being Led By Its Strong Fundamentals?

Syngen Biotech (GTSM:8279) Seems To Use Debt Quite Sensibly

Dec 16
Syngen Biotech (GTSM:8279) Seems To Use Debt Quite Sensibly

Syngen Biotech's (GTSM:8279) Earnings Are Growing But Is There More To The Story?

Nov 25
Syngen Biotech's (GTSM:8279) Earnings Are Growing But Is There More To The Story?

Revenue & Expenses Breakdown

How Syngen BiotechLtd makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

TPEX:8279 Revenue, expenses and earnings (TWD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Mar 241,86126230448
31 Dec 231,83727529447
30 Sep 231,89028731346
30 Jun 231,96130830245
31 Mar 231,99632929746
31 Dec 221,93132128045
30 Sep 221,84831924547
30 Jun 221,65529622247
31 Mar 221,54526220948
31 Dec 211,47123819750
30 Sep 211,37221219748
30 Jun 211,36320320148
31 Mar 211,34921719646
31 Dec 201,31121619343
30 Sep 201,31022518644
30 Jun 201,31721119047
31 Mar 201,30119519349
31 Dec 191,29718919053
30 Sep 191,28118119054
30 Jun 191,24218418151
31 Mar 191,15215316750
31 Dec 181,08013416646
30 Sep 1899711615844
30 Jun 1895912615141
31 Mar 1894414314640
31 Dec 1795614914440
30 Sep 1793414513640
30 Jun 1787211713342
31 Mar 178099613242
31 Dec 167699012543
30 Sep 167317911849
30 Jun 166736811047
31 Mar 166396510147
31 Dec 15644679746
30 Sep 15626679840
30 Jun 156265910042
31 Mar 156004510044
31 Dec 14556359946
30 Sep 14476229250
30 Jun 1439598554
31 Mar 14335127850
31 Dec 13275157045

Quality Earnings: 8279 has high quality earnings.

Growing Profit Margin: 8279's current net profit margins (14.1%) are lower than last year (16.5%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 8279's earnings have grown by 12.2% per year over the past 5 years.

Accelerating Growth: 8279's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: 8279 had negative earnings growth (-20.4%) over the past year, making it difficult to compare to the Pharmaceuticals industry average (2.8%).


Return on Equity

High ROE: 8279's Return on Equity (12.7%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.